Nawi, Lovely Honey Joy M.

HRN: 13-93-91  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2022
CEFUROXIME 1.5GM (VIAL)
07/21/2022
07/28/2022
IVT
1.5gm
Q8H
G1P0 41 2/7 Weeks; UTI
Waiting Final Action 
07/23/2022
CEFOTAXIME 500MG (VIAL)
07/23/2022
07/30/2022
PO
500mg
Q12
Post Op Prophylaxis
07/23/2022
CEFUROXIME 500MG (TAB)
07/23/2022
07/30/2022
ORAL
500mg
Q12
Post OP (Cesarean Section)
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: